The past week ushered in new discoveries of combination treatments for lung cancer and lymphoma, and nonopioid pain relief inspired by venomous sea creatures.
UCSF scientists are testing a therapeutic vaccine that can prompt the immune system to launch an attack against a cancer.
Doctors in Paris discovered that when they treated an HIV-infected lung cancer patient with Opdivo, reservoirs of the virus shrunk.
Scientists at Tufts University have created an “organ on a chip” that could be used to study inflammatory bowel disease and other gut disorders.
Engineers at Duke University say they’ve created an artificial heart muscle that helps repair damage in patients who have suffered heart attacks.
Sequencing the genes of 116 houseflies led scientists in Singapore to propose using the insects as early warning systems for emerging outbreaks.
AstraZeneca is allowing U.K. scientists access to an early-stage pipeline med in the hope it can help patients with head and neck cancer.
Scientists have identified viral changes and antibody features that could provide a possible template for HIV vaccine design.
Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms.
The enzyme PTK6 could be targeted to quell the growth of estrogen receptor-positive breast cancer, a common form of the disease.